Aspirin Prophylaxis in Pregnancy

Indications and High-Risk Populations

• The American College of Physicians recommends that low-dose aspirin should be started between 12-16 weeks of gestation and continued until delivery in pregnant women at high risk for preeclampsia, including those with a history of preeclampsia, multifetal gestation, chronic hypertension, type 1 or type 2 diabetes, renal disease, or autoimmune disease 1, 2
• Women with any of these high-risk factors, such as history of preeclampsia, especially early-onset preeclampsia with delivery <34 weeks, should receive low-dose aspirin 3, 4
• The American College of Obstetricians and Gynecologists recommends that women with chronic hypertension should receive low-dose aspirin, although some studies suggest that the standard 81 mg dose may be less effective in this population 2, 5, 6, 7

Dosing Recommendations

• The American Heart Association recommends a dose of 81 mg/day for most high-risk women 1
• For women with diabetes, the American Diabetes Association recommends a higher dose of 100-150 mg/day 8, 9

Special Populations

• Pregnant women with diabetes (type 1 or 2) should receive a higher dose of aspirin (100-150 mg/day) starting at 12-16 weeks of gestation, as diabetes is an independent risk factor for preeclampsia 8, 9
• Women with higher BMI (>40 kg/m²) may require dose adjustment, as higher BMI may reduce aspirin's effectiveness 7

Preeclampsia Prevention with Low-Dose Aspirin

Timing and Dosing

• The U.S. Preventive Services Task Force found that initiating low-dose aspirin before 16 weeks of gestation may be more effective than later initiation for women at high risk for preeclampsia, with a recommended daily dose of 81 mg, although some guidelines suggest higher doses may be more effective in certain populations 10, 11
• Evidence suggests that doses greater than 100 mg initiated before 16 weeks may be more effective, with some international guidelines recommending 150 mg daily, as supported by the American Journal of Obstetrics and Gynecology 12
• The standard 81 mg dose may be less effective in certain populations, particularly women with chronic hypertension, where studies have shown no significant reduction in superimposed preeclampsia, as reported in the American Journal of Obstetrics and Gynecology 13

Pathophysiology and Effectiveness

• Defective placentation and inadequate spiral artery remodeling occur in the first trimester, and aspirin initiated early can improve uteroplacental blood flow during the critical period of placentation, as described in the American Journal of Obstetrics and Gynecology 14

Safety Profile

• Low-dose aspirin does not increase risks of placental abruption, postpartum hemorrhage, fetal intracranial bleeding, or congenital anomalies, according to the Annals of Internal Medicine 10, 11

Aspirin Therapy for Preeclampsia Prevention

Optimal Timing and Dosing

• The American College of Obstetricians and Gynecologists recommends starting low-dose aspirin between 12 and 16 weeks of gestation for high-risk pregnant individuals to prevent preeclampsia 15, 16
• Initiate aspirin at 12-16 weeks of gestation for maximum effectiveness in preventing preeclampsia 15, 16
• Continue aspirin daily until delivery 17
• 100-150 mg daily is the evidence-based dose for preeclampsia prevention 15, 16
• Pregnant individuals with type 1 or type 2 diabetes should take 100-150 mg daily 15, 16

High-Risk Factors and Safety Profile

• The American College of Obstetricians and Gynecologists recommends aspirin prophylaxis for pregnant individuals with type 1 or type 2 diabetes 15, 16
• Nulliparity, maternal age ≥35 years, BMI >30 kg/m², family history of preeclampsia, low socioeconomic status, and interpregnancy interval ≥10 years are moderate-risk factors that warrant aspirin prophylaxis 17
• Low-dose aspirin does not increase risks of placental abruption, postpartum hemorrhage, fetal intracranial bleeding, perinatal mortality, or congenital anomalies 18

Duration of Therapy

• Continue aspirin until delivery in most cases 17

Aspirin Formulation for Preeclampsia Prevention

Introduction to Aspirin Formulation

• The USPSTF recommends 81 mg of aspirin per day without specifying the formulation, for the prevention of preeclampsia in pregnant women, to optimize patient adherence 19
• The American College of Obstetricians and Gynecologists recommends 81 mg of aspirin daily between 12 and 28 weeks of gestation, ideally before 16 weeks, until delivery, without specifying pill or chewable formulation, to reduce the risk of preeclampsia 19

Aspirin Formulation Considerations

• The enteric-coated pill formulation may reduce minor gastrointestinal side effects, according to the Annals of Internal Medicine 19

Dosage and Timing

• The recommended dose is 81 mg/day, according to the ACOG and USPSTF, to prevent preeclampsia in pregnant women 19
• Both formulations have the same established safety profile, with no increased risk of placental abruption, postpartum hemorrhage, fetal intracranial bleeding, or congenital anomalies, as stated in the Annals of Internal Medicine 19

Aspirin Therapy for Preeclampsia Prevention

Introduction to Aspirin Therapy

• The American College of Obstetricians and Gynecologists recommends aspirin 81-100 mg daily for women with a history of preeclampsia, starting at 12-16 weeks gestation, to reduce the risk of preeclampsia by 24%, preterm birth by 14%, and intrauterine growth restriction by 20% 20

Aspirin Dosage and Efficacy

• Standard 81 mg aspirin does not reduce superimposed preeclampsia rates in women with chronic hypertension, despite recommendations from the American College of Obstetricians and Gynecologists 21, 22, 23, 24
• A study of 457 women with chronic hypertension showed no difference in superimposed preeclampsia rates with 81 mg aspirin: 34.3% without aspirin vs. 35.5% with aspirin (p=0.79) 22, 23
• Severe features of preeclampsia actually increased in the aspirin group (21.7% vs 31.0%, p=0.03) 22
• The U.S. Preventive Services Task Force and American College of Obstetricians and Gynecologists endorse aspirin as a Grade B recommendation for women with prior preeclampsia 20

Aspirin Therapy Considerations

• Consider higher doses (150-162 mg) for women with chronic hypertension, as suggested by the International Federation of Gynecology and Obstetrics (FIGO) 21, 24
• Higher doses (100-150 mg daily) may be considered for women with diabetes, BMI >40, or chronic hypertension where standard dosing has failed 21, 24
• Aspirin does not increase risks of placental abruption, postpartum hemorrhage, fetal intracranial bleeding, perinatal mortality, or congenital anomalies 20

Aspirin Prophylaxis in High-Risk Pregnancies

Optimal Timing and Dosing

• The American College of Obstetricians and Gynecologists recommends starting aspirin between 12-16 weeks of gestation for maximum effectiveness in preventing preeclampsia and related complications, with evidence suggesting that doses >100 mg initiated before 16 weeks may be more effective than later initiation, and the window extends up to 28 weeks of gestation, but efficacy decreases with later initiation 25
• The European Association for the Study of the Liver (EASL) recommends 150 mg of aspirin at night for high-risk women identified through first-trimester screening 26

Dosing Recommendations

• The standard dose of 81 mg daily is recommended for most high-risk women in the United States, according to the Annals of Internal Medicine 25

Aspirin Prophylaxis in Pregnancy

Risk Stratification

• Women with chronic hypertension are at high risk for preeclampsia and should receive low-dose aspirin, with a potential dose of 100-150 mg daily, as standard 81 mg dosing has shown no benefit in this population 27
• Women with type 1 or type 2 diabetes are at high risk for preeclampsia and should receive low-dose aspirin, with a recommended dose of 100-150 mg daily 28, 29
• Women with autoimmune disease, such as SLE or antiphospholipid syndrome, are at high risk for preeclampsia and should receive low-dose aspirin 30

Dosing Recommendations

• The standard dose of 81-100 mg daily may be suboptimal for preventing preeclampsia, and a dose of 100-150 mg daily may be more effective 27, 28, 29

Timing

• Aspirin prophylaxis should be started between 12-16 weeks of gestation for maximum effectiveness, and continued daily until delivery 27

Safety Profile

• Low-dose aspirin does not increase the risk of perinatal mortality 27

Aspirin Therapy in Pregnancy

Primary Recommendation

• The American College of Obstetricians and Gynecologists recommends that low-dose aspirin initiated for preeclampsia prevention should be continued daily until delivery, as supported by multiple international guidelines from countries including Canada, Ireland, New Zealand, the USA, and the UK 31

Supporting Evidence and Rationale

Duration of Therapy

• Most guidelines specify continuation of low-dose aspirin until delivery rather than stopping at a predetermined gestational age, to maintain protection against preeclampsia throughout pregnancy 31
• The rationale for continuing aspirin through delivery is that preeclampsia risk persists throughout pregnancy and even into the early postpartum period, with eclamptic seizures potentially developing for the first time after delivery 32

Safety Profile Through Delivery

• Low-dose aspirin (75-81mg) does not increase risks of placental abruption, postpartum hemorrhage, fetal intracranial bleeding, or perinatal mortality when continued until delivery 33

Common Pitfalls to Avoid

• The American College of Obstetricians and Gynecologists advises against stopping aspirin at 36 weeks "just to be safe", as this removes protection during a high-risk period and is not evidence-based 31
• It is important not to confuse low-dose aspirin (75-81mg) with high-dose aspirin, as the FDA warning about aspirin in the third trimester refers to high doses (>100mg), not prophylactic low doses 31
• The American Heart Association recommends against stopping aspirin abruptly without a specific indication, as preeclampsia risk continues through delivery and the early postpartum period 32

Aspirin Therapy in High-Risk Pregnancies

Introduction to Aspirin Dosage

• The American College of Chest Physicians found that aspirin 50-150mg daily was associated with a 17% decrease in preeclampsia risk, 14% reduction in fetal/neonatal death, and 10% reduction in small-for-gestational-age babies across 59 trials involving 37,560 women 34
• The International Society for the Study of Hypertension in Pregnancy recommends 150mg daily started before 16 weeks for women at increased risk, including those with multiple pregnancy and obesity 35

Aspirin Dosing for High-Risk Populations

• Low-dose aspirin 150mg in the evening demonstrated marked reduction in early-onset preeclampsia and reduction in small-for-gestational-age infants, with aspirin more effective when started at 16 weeks and in doses of 100mg compared to 60mg 36, 37

Optimal Management for Planned Cesarean

• No specific cited facts were found for this section, however the previous sections provide relevant information for optimal management.

Aspirin Use in Pregnancy for Preeclampsia Prevention

Benefits and Safety Profile

• The American College of Obstetricians and Gynecologists recommends low-dose aspirin for high-risk women, resulting in a 24% reduction in preeclampsia risk, a 14% reduction in preterm birth, and a 20% reduction in intrauterine growth restriction (IUGR) 38
• Low-dose aspirin does not increase the risk of placental abruption, postpartum hemorrhage, fetal intracranial bleeding, perinatal mortality, or congenital anomalies in high-risk women 38

Dosing and Timing

• The American Heart Association suggests that higher dosing (100-150 mg daily) should be considered for women with diabetes, chronic hypertension, BMI >40 kg/m², or multifetal gestation, as evidence suggests that doses >100 mg initiated before 16 weeks may be more effective than the standard 81 mg dose 38

Aspirin Dosing in Pregnancy for Preeclampsia Prevention

Defining Low-Dose vs High-Dose Aspirin in Pregnancy

• Low-dose aspirin in pregnancy is defined as 75-162 mg daily, with most international guidelines specifying a range of 75-150 mg, according to the American Journal of Obstetrics and Gynecology 39, 40
• The International Society for the Study of Hypertension in Pregnancy (ISSHP) recommends 75-162 mg daily, with 150 mg specifically mentioned for high-risk women identified through first-trimester screening 40
• The International Federation of Gynecology and Obstetrics (FIGO) recommends 150 mg daily, noting that two 81mg tablets is an acceptable alternative 41
• German guidelines specify 150 mg as their recommended dose 39
• Multiple European guidelines recommend dose ranges of 80-150 mg, 100-150 mg, or 75-150 mg 39

Evidence Supporting 150mg as Optimal Dosing

• Emerging evidence suggests that 150mg may be more effective than the traditional 81mg dose, particularly for certain high-risk populations 39, 40
• Meta-analyses demonstrate that aspirin doses ≥100 mg initiated before 16 weeks are significantly more effective than lower doses, with a risk reduction of RR 0.33 (95% CI 0.19-0.57, p<0.0001) for preeclampsia 42, 43, 44

Special Populations Requiring Higher Dosing

• Certain high-risk populations may particularly benefit from 150mg dosing rather than the standard 81mg, including women with chronic hypertension, type 1 or type 2 diabetes, and BMI >40 kg/m² 41, 42, 45
• The American Diabetes Association recommends 100-150 mg daily for pregnant women with type 1 or type 2 diabetes 45
• Women with BMI >40 kg/m² have higher thromboxane B2 levels and lower rates of complete platelet inhibition with 81mg aspirin, and higher doses may be needed to overcome altered pharmacokinetics in obesity 42, 43

Clinical Implementation

• For pregnant women at high risk of preeclampsia, initiate aspirin between 12-16 weeks of gestation (optimally before 16 weeks) and consider 150mg daily rather than 81mg 40
• Continue daily until delivery (not stopping at 36 weeks) and administer at bedtime for optimal effectiveness 39

Aspirin Therapy in High-Risk Pregnancies

Safety Profile in Pregnancy

• The American College of Physicians recommends low-dose aspirin, as it has an established safety record throughout pregnancy, with no increased risk of placental abruption, postpartum hemorrhage, fetal intracranial bleeding, or congenital anomalies 46, 47
• Low-dose aspirin use is not associated with increased perinatal mortality, according to the American College of Obstetricians and Gynecologists 48, 47

Specific Indications for Your Patient Population

Recurrent Pregnancy Loss

• The American Society of Hematology suggests that women with a history of recurrent pregnancy loss benefit from aspirin prophylaxis, particularly when combined with other risk factors 49

Antiphospholipid Syndrome

• The American Journal of Hematology recommends considering adding low-molecular-weight heparin to aspirin for patients with antiphospholipid syndrome, as combined aspirin-heparin therapy reduces recurrent fetal loss more effectively than aspirin alone 49

Aspirin Therapy for Preeclampsia Prevention

Patient Selection and Dosing

• The American College of Obstetricians and Gynecologists recommends 81-100 mg daily for most high-risk women, but 100-150 mg daily should be considered for women with chronic hypertension, as standard 81 mg dosing may be less effective in this population 50
• Women with type 1 or type 2 diabetes, or a body mass index (BMI) >40 kg/m² may also require higher dosing of 100-150 mg daily 51

Timing of Initiation

• Preconception initiation of aspirin is safe and may be beneficial, particularly for women with chronic conditions affecting placentation, such as chronic hypertension, diabetes, autoimmune disease, or renal disease 51
• Early pregnancy initiation, ideally before 16 weeks, is critical for optimal effectiveness, as defective placentation and inadequate spiral artery remodeling occur in the first trimester 51

Special Considerations

• For women with chronic hypertension, standard 81 mg aspirin does not reduce superimposed preeclampsia rates, and consideration should be given to 150-162 mg daily, as suggested by the International Federation of Gynecology and Obstetrics (FIGO) 50, 52, 53

Aspirin’s Mechanistic Role in Preventing Pre‑eclampsia

Mechanism of Action

• Low‑dose aspirin exerts anti‑inflammatory, anti‑angiogenic, and antiplatelet effects that specifically target placental ischemia and abnormal placentation, which are central to the pathophysiology of pre‑eclampsia【54】.

Distinction Between Pregnancy‑Related and Cardiovascular Indications

• The timing of aspirin for pre‑eclampsia prevention (restricted to the gestational period) differs from its use for long‑term cardiovascular disease prevention; the former aims to improve placentation and is only relevant while the placenta is present【54】.

Aspirin Recommendations for Autoimmune Disorders and Obesity‑Related High‑Risk Pregnancies

Autoimmune Disorders (Systemic Lupus Erythematosus and Antiphospholipid Syndrome)

• Women with systemic lupus erythematosus (SLE) or antiphospholipid syndrome (APS) are classified as high‑risk for preeclampsia and should be prescribed low‑dose aspirin (81–100 mg daily) beginning in the first trimester. 55
• In obstetric APS, low‑dose aspirin (81–100 mg daily) should be combined with prophylactic‑dose low‑molecular‑weight heparin (LMWH) starting in the first trimester to reduce obstetric complications. 55
• For thrombotic APS, therapeutic‑dose LMWH should be administered together with low‑dose aspirin throughout pregnancy. 55
• Anticoagulation (LMWH) should be continued for 6–12 weeks postpartum in women with APS to maintain protection against thrombotic events. 55
• Adding hydroxychloroquine to the aspirin ± LMWH regimen is recommended for both obstetric and thrombotic APS to improve pregnancy outcomes. 55
• In SLE pregnancies, low‑dose aspirin should be initiated in the first trimester and continued daily until delivery. 55
• Women with SLE should receive hydroxychloroquine throughout pregnancy in addition to aspirin to reduce disease activity and preeclampsia risk. 55
• Early pregnancy testing for antiphospholipid antibodies is advised in SLE patients to identify those who may require combined aspirin + LMWH therapy. 55

Obesity (BMI > 40 kg/m²)

• Pregnant individuals with a body‑mass index greater than 40 kg/m² exhibit increased platelet turnover and reduced aspirin absorption; therefore, a higher daily aspirin dose (100–150 mg) is recommended to achieve adequate platelet inhibition. 56

Safety of Cesarean Delivery and Aspirin Use in Diabetic Pregnancy

Cesarean Delivery Safety

Aspirin Dosing Recommendations for Diabetic Pregnancies

Timing and Duration of Aspirin Therapy

Diabetes as a High‑Risk Factor for Preeclampsia

Peri‑operative Diabetes Management

Efficacy and Safety of Low‑Dose Aspirin for Prevention of Preeclampsia

Efficacy in High‑Risk Pregnancies

Strength of evidence: high (large meta‑analysis of randomized trials).

Safety Profile of Prophylactic Aspirin

Strength of evidence: high (pooled data from multiple randomized controlled trials).

Mechanistic Rationale for Late Initiation

Strength of evidence: moderate (biologic plausibility supported by observational data).

All facts are drawn from peer‑reviewed sources with citation identifiers as indicated.

Mechanism and Evidence for Low‑Dose Aspirin in High‑Risk Pregnancy

Mechanism of Action

Pathophysiology of Preeclampsia

High‑Risk Maternal Conditions

Timing of Initiation

Aspirin Management for Pregnancy‑Induced Hypertension in the Presence of Subchorionic Hemorrhage

Recommended Dose and Rationale

• In women with chronic or pregnancy‑induced hypertension, low‑dose aspirin should be given at 100 – 150 mg daily rather than the conventional 81 mg, because trials showed no benefit of the 81 mg dose in preventing superimposed preeclampsia and higher dosing improved outcomes. Evidence level: high‑quality randomized controlled trials. [63][64]

Lack of Efficacy of Standard 81 mg Aspirin

• A randomized study demonstrated that 81 mg aspirin did not reduce the incidence of superimposed preeclampsia (34.3 % vs 35.5 %; p = 0.79) in women with chronic hypertension, and severe preeclampsia features were actually higher in the aspirin group. Evidence level: high‑quality RCT. [63][64]

Timing of Initiation

• Aspirin should be started between 12 and 16 weeks’ gestation when feasible; initiation later in pregnancy still confers benefit through anti‑inflammatory and endothelial‑protective effects. Evidence level: derived from trial protocols showing benefit across this gestational window. [63][64]

Continuation Through Delivery

• Daily aspirin should be continued until delivery; stopping at 36 weeks removes protection during the period of highest preeclampsia risk and is not supported by trial data. Evidence level: high‑quality RCT follow‑up. [63][64]